A carregar...
Profile of Margetuximab: Evidence to Date in the Targeted Treatment of Metastatic HER2-positive Breast Cancer
Ilana Schlam,1 Raquel Nunes,2 Filipa Lynce3 1Department of Hematology and Oncology, Tufts Medical Center, Boston, MA, USA; 2Johns Hopkins Women’s Malignancies Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 3Breast Medical Oncology, Dana Farber Cancer Institute, Boston, MA,...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2022-04-01
|
Colecção: | OncoTargets and Therapy |
Assuntos: | |
Acesso em linha: | https://www.dovepress.com/profile-of-margetuximab-evidence-to-date-in-the-targeted-treatment-of--peer-reviewed-fulltext-article-OTT |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|